Repeated Remote Ischemic Conditioning Protects Against Doxorubicin Cardiotoxicity

• Derek J. Hausenloy, MD, PhD,
• Choon Ta Ng, MD,
• Jun Hua Chong, MD

Affiliations

Derek J. Hausenloy, MD, PhD

National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore; Cardiovascular & Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore; Yong Loo Lin School of Medicine, National University Singapore, Singapore; The Hatter Cardiovascular Institute, University College London, London, United Kingdom; Cardiovascular Research Center, College of Medical and Health Sciences, Asia University, Taichung City, Taiwan; Tecnologico de Monterrey, Centro de Biotecnologia-FEMSA, Nuevo Leon, Mexico; Address for correspondence: Dr. Derek J. Hausenloy, Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore, 8 College Road, Singapore 169857.

Choon Ta Ng, MD

Department of Cardiology, National Heart Centre Singapore, Singapore

Jun Hua Chong, MD

Cardiovascular & Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore; Department of Cardiology, National Heart Centre Singapore, Singapore